IFP Advisors Inc boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 9,923 shares of the exchange traded fund’s stock after acquiring an additional 834 shares during the quarter. IFP Advisors Inc’s holdings in SPDR S&P Biotech ETF were worth $945,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in XBI. Cypress Capital Management LLC WY acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at $119,000. Rockefeller Capital Management L.P. purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $130,000. WP Advisors LLC purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $133,000. Trust Co. of Vermont purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $136,000. Finally, Squar Milner Financial Services LLC purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $139,000.

Shares of XBI stock opened at $93.30 on Tuesday. SPDR S&P Biotech ETF has a fifty-two week low of $74.44 and a fifty-two week high of $101.55.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Article: Stock Symbol

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.